$莱斯康制药(LXRX)$ 8-K - Current report Filed: 2015-05-22 AccNo: 0001062822-15-000027 Size: 42 KBItem 3.03: Material Modifications to Rights of Security HoldersItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接